Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy with ABMT in Refractory Ovarian Cancer
NCT00002474Phase 2Completed
- Sponsor
- Loyola University Chicago
- Start
- Feb 1991
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, mitoxantrone, carboplatin in ovarian epithelial cancer, sponsored by Loyola University Chicago. Started Feb 1991; status: completed.
02
Drugs
cyclophosphamidemitoxantronecarboplatin
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00002474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002474.